HOIST Co.
Latest round
- Series A
Last raised
- May 2023
Total raised
- $9.1M
Investors
- 1
About HOIST Co.
, Ltd. operates as a pharmaceutical research and development company specializing in cancer treatment drugs. The company engages in the research, development, consultancy, and sale of prescription drugs and drug discovery equipment for cancer treatment. The other services offered by the firm are consulting on industry-academia collaboration, research and development, manufacturing, sales, and consulting of health tech products. HOIST also offers a variety of healthcare information services over the Internet. As of April 2023, the products in the company’s pipeline are bladder cancer drugs and epi transcriptomics drug discovery.
Who invested in HOIST Co.
1 investor across 4 rounds
See all investors in HOIST Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HOIST Co.
Who invested in HOIST Co.?
HOIST Co. has 1 investor on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HOIST Co. raised?
HOIST Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did HOIST Co. last raise money?
HOIST Co.'s most recent round on record is a Series A, in May 2023.
What does HOIST Co. do?
HOIST Co. is a pharmaceuticals company.
Where is HOIST Co. headquartered?
HOIST Co. is headquartered in Japan.
Which VCs invest in companies like HOIST Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at HOIST Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like HOIST Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.